Biopsies are performed by a wide range of medical specialists, in settings that span hospital operating rooms, outpatient clinics, ambulatory surgical centers, and sometimes a doctor’s office with little more than a local anesthetic and an ultrasound machine. The specialist who performs yours depends almost entirely on where in the body the tissue needs to come from, and that same factor largely determines the setting, the type of anesthesia used, and how long the whole process takes. The landscape is broader and more varied than most people expect.
The Most Common Settings
For many people, the word “biopsy” conjures images of a hospital procedure room, and that is accurate for a good portion of cases. Hospitals offer the full range of imaging equipment, anesthesia options, and emergency support that complex or deep-tissue biopsies demand. Brain biopsies, deep abdominal organ biopsies, and procedures on critically ill patients almost always happen in a hospital. But a large and growing share of biopsies take place outside the traditional inpatient setting.
Outpatient clinics and ambulatory surgical centers handle many biopsies that were once done with overnight hospital stays. Kidney biopsies are a good example: a study of 475 percutaneous kidney biopsies performed in an ambulatory outpatient setting, with patients observed for six hours before discharge, found an overall complication rate of about 8%, with major complications requiring intervention occurring in roughly 1% of cases.1Clinical Nephrology. Safety and predictors of complications of renal biopsy in the outpatient setting That is low enough that many centers now routinely send kidney biopsy patients home the same day rather than admitting them for 24 hours of monitoring.
Freestanding outpatient surgical centers have also taken on procedures that sound more invasive than they turn out to be. Sentinel lymph node biopsies for skin cancers around the eye, for instance, have been safely performed in these centers, with shorter procedure times and no complications compared to the same procedure done in hospitals.2PubMed. Safety and feasibility of performing sentinel lymph node biopsy for periorbital malignancies at freestanding outpatient surgical centers The patients selected for outpatient centers tend to be younger and healthier, which is part of the reason the complication rates look so good. If you have significant medical issues or are on blood thinners, you are more likely to be directed to a hospital.
Skin biopsies and many breast biopsies happen in an even simpler setting: a dermatologist’s or surgeon’s office, with local numbing and no sedation at all. Prostate biopsies are commonly done in a urologist’s office using ultrasound guidance. The key point is that “where” you go is not a choice you usually make independently. Your referring physician and the specialist performing the procedure choose the setting based on what tissue is being sampled, how deep it is, what imaging is needed, and your overall health.
Which Specialist Performs Which Biopsy
The specialist who does the procedure is matched to the organ system involved. There is no single “biopsy doctor.” Here is how the responsibilities typically break down:
- Dermatologists: skin lesions, moles, and rashes. These are usually punch biopsies, shave biopsies, or excisional biopsies done in an office with local anesthetic.
- Surgeons: breast lumps (often a breast surgeon), lymph nodes, soft-tissue masses, and any situation where the biopsy itself may double as treatment by removing the entire lesion. Orthopedic surgeons handle bone tumor biopsies, and for certain smaller bones an excisional biopsy can serve as both diagnosis and definitive treatment in one step.3PubMed. Excisional biopsy for bone tumours
- Interventional radiologists: deep organ biopsies of the liver, kidney, lung, and other internal structures. They use imaging (ultrasound, CT, or MRI) to guide needles precisely to a target without open surgery. Liver biopsies, for example, are a core part of interventional radiology practice, performed using either percutaneous or transjugular approaches depending on the patient’s clotting ability and anatomy.4PubMed Central. Image-Guided Liver Biopsy: Perspectives from Interventional Radiology
- Gastroenterologists: biopsies of the esophagus, stomach, small intestine, and colon during endoscopy. They thread a scope through the mouth or rectum and snip tissue samples with tiny forceps at the tip. European guidelines for suspected eosinophilic esophagitis, for instance, recommend at least six biopsies taken from different parts of the esophagus during a single endoscopy session.5PubMed. Endoscopic tissue sampling – Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts For masses deeper than the gut wall, gastroenterologists can also use endoscopic ultrasound to guide fine-needle aspiration into pancreatic lesions, bile duct masses, and nearby lymph nodes.6Best Practice & Research Clinical Gastroenterology. Endoscopic ultrasound-guided fine-needle aspiration biopsy and trucut biopsy in gastroenterology – An overview
- Pulmonologists: lung lesions, especially those reachable through the airways. They use bronchoscopy, sometimes augmented with newer navigation technologies, to reach nodules deep in the lung.7PubMed Central. Bronchoscopic biopsy of peripheral pulmonary lesions in 2020: a review of existing technologies Lesions closer to the chest wall may instead be biopsied by an interventional radiologist using a needle guided by CT.
- Urologists: prostate biopsies, typically using a transrectal or transperineal approach under ultrasound guidance in an office or outpatient center.
- Hematologists and pathologists: bone marrow biopsies, which involve pushing a special needle into the hip bone. Both hematologists and trained pathologists perform these, and the resulting sample goes through a detailed workup of smears, sections, and volumetric analysis.8Oxford Academic (American Journal of Clinical Pathology). Bone Marrow Aspiration and Trephine Biopsy: An Approach to a Thorough Study
- Neurosurgeons: brain and brainstem biopsies, performed using stereotactic guidance that locks a needle’s trajectory to millimeter-level precision.
In practice, there can be overlap. A lung nodule might be biopsied by an interventional radiologist through the chest wall or by a pulmonologist through the airways, depending on where the nodule sits and local expertise. A liver mass might be sampled by a hepatologist, a radiologist, or a surgeon. The referral process typically routes you to whoever has the best combination of access and experience for your specific lesion.
Needle Types and How They Differ
Two main needle categories dominate: fine-needle aspiration and core-needle biopsy. Fine-needle aspiration uses a thin needle to suction out individual cells, while core-needle biopsy uses a slightly larger, spring-loaded needle to extract a small cylinder of intact tissue. The distinction matters because having intact tissue architecture gives the pathologist more to work with.
For detecting malignant versus benign disease in the lung, both approaches perform well, but core-needle biopsies tend to be more accurate when the pathologist needs to identify the specific subtype of cancer.9PubMed Central. Fine-needle aspiration biopsy versus core-needle biopsy in diagnosing lung cancer: a systematic review A meta-analysis comparing the two for malignant lymph nodes in the neck found core-needle biopsy about 1.3 times more sensitive for detecting malignancy, with pooled sensitivity around 94% versus 72% for fine-needle aspiration.10PubMed Central. Fine-Needle Aspiration Versus Core Needle Biopsy for Malignant Cervical Lymphadenopathy: A Meta-Analysis and Systematic Review That doesn’t mean fine-needle aspiration is obsolete. For thyroid nodules, superficial lymph nodes, and situations where the risk of bleeding needs to be minimized, it remains the go-to technique. Your specialist picks the needle type based on what information they need and where the target sits.
Imaging Guidance and Why It Matters
Most biopsies of internal organs rely on imaging to steer the needle to the right spot. The two workhorses are ultrasound and CT. Ultrasound is fast, portable, uses no radiation, and lets the operator see the needle moving in real time. CT provides better spatial detail and can reach lesions that ultrasound simply cannot visualize, particularly in the lung, where even a thin layer of air between the lesion and the chest wall blocks the ultrasound signal entirely.11Frontiers in Oncology. Ultrasound versus computed tomography guided percutaneous needle biopsy for subpleural pulmonary lesions The bony ribcage also blocks about 30% of the lung’s pleural surface from ultrasound view.
For lung lesions that do sit against the chest wall, ultrasound-guided biopsy is a viable and sometimes preferred option. These tend to be larger lesions with more pleural contact. When lesions are smaller, deeper, or surrounded by aerated lung, CT guidance is necessary because the needle path and target can still be seen even if a small pocket of air develops during the procedure.12PubMed Central. Ultrasound-guided versus computed tomography-scan guided biopsy of pleural-based lung lesions MRI-guided biopsies are used less often but play a specific role in prostate and breast biopsies where MRI gives the clearest picture of suspicious areas.
What Happens to the Tissue After Collection
The specialist who takes the sample is not usually the one who diagnoses it. That job falls to a pathologist, a physician who examines tissue under a microscope and runs specialized stains and molecular tests. This behind-the-scenes step is where the diagnosis actually gets made, and it is worth understanding because it directly affects how long you wait for results.
Once the tissue arrives in the lab, it is fixed in preservative, embedded in wax, sliced into extremely thin sections, stained, and mounted on slides. If the sample is small, the lab may cut multiple sections from a single block and distribute them across several slides to avoid wasting tissue, especially when molecular testing might also be needed.13American Journal of Clinical Pathology. Pathologists at the Leading Edge of Optimizing the Tumor Tissue Journey for Diagnostic Accuracy and Molecular Testing
Straightforward cases in one tertiary teaching hospital were reported within three to five days about 74% of the time.14International Journal of Medical and Pharmaceutical Research. Study of Turnaround Time of Surgical Pathology Reports in a tertiary care teaching hospital Cases that needed a second internal opinion took longer, with roughly 40% completed in three to five days but another 20% stretching past ten days. And if the pathology department sends the case to an outside expert for a second opinion, the delay can be substantial: one study of referred cases found a mean turnaround of 22 days from specimen receipt to final report, with only a quarter finished within two weeks.15European Journal of Surgical Oncology. Patterns of outgoing histopathology case referrals from a district general hospital
That referral study also found that about 31% of cases sent for expert review had their diagnosis changed. In ten of those cases, the change flipped from benign to malignant or vice versa. This is one reason why second opinions in pathology exist and why some hospitals build routine double-reading into their workflow, particularly before multidisciplinary tumor board meetings. One hospital that adopted routine double-reading found that about 1% of cases had a discordant diagnosis with potential clinical significance, meaning a wrong call that could have changed treatment.16PubMed. Improved quality of patient care through routine second review of histopathology specimens prior to multidisciplinary meetings That sounds small in percentage terms, but for the patients involved, catching it matters enormously.
Complications and Pain Management
Every biopsy carries some risk of bleeding, infection, or damage to nearby structures, but the level of risk varies dramatically depending on what is being biopsied and how. Skin biopsies and superficial lymph node biopsies are low-risk procedures with minimal complications. Deep-tissue needle biopsies carry more risk. For CT-guided lung biopsies, pneumothorax (a pocket of air leaking into the space around the lung) is the signature complication, reported in roughly 20% of cases on average across published studies.17PubMed Central. Pneumothorax after transthoracic needle biopsy of lung lesions under CT guidance Most of these are small and resolve on their own. The real concern is a pneumothorax that grows and requires a chest tube, which is less common. Lesion size, depth within the lung, and the presence of emphysema are the main factors that raise the risk.18PubMed. Complications of CT-guided percutaneous needle biopsy of the chest: prevention and management
Pain management varies by procedure. Skin biopsies use a small injection of local anesthetic and cause brief stinging. Prostate biopsies have historically been uncomfortable, but techniques like periprostatic nerve blocks and perianal local anesthetic injections substantially reduce pain during the procedure compared to lidocaine gel alone.19Urology. Comparison of different local anesthesia techniques during TRUS-guided biopsies: A prospective pilot study Deep organ biopsies often use conscious sedation or, for more complex procedures, general anesthesia. Your specialist should explain what to expect for pain control before the procedure and will typically give you instructions about eating, drinking, and medications.
Speaking of medications, you will almost certainly be asked about blood thinners and antiplatelet drugs like aspirin. Practices vary by institution and biopsy type. Some centers routinely stop these medications days before the procedure; others have found that continuing low-dose aspirin does not significantly increase bleeding in certain biopsy types.20Nephrology Dialysis Transplantation. Is it necessary to stop antiplatelet agents before a native renal biopsy? Do not stop any medication on your own; follow whatever instructions your procedure team gives you.
The Referral Path and How You Get There
Most people do not self-refer for a biopsy. The typical path starts with a primary care physician or a specialist who notices something that needs tissue confirmation. A suspicious mole, an abnormal imaging scan, or a blood test pointing to a possible malignancy triggers the referral. For skin cancers in particular, the general practitioner plays a central role. A population-based study of melanoma diagnosis in Queensland found that about 85% of patients saw a general practitioner at least once during the diagnostic process, most commonly as the first consultation before referral to a surgeon for definitive biopsy and diagnosis.21Melanoma Research. Clinical pathways to diagnose melanoma: a population-based study The pathways were surprisingly diverse, involving various combinations of general practitioners, skin clinics, surgeons, and dermatologists.
If your primary care doctor refers you to a specialist for a biopsy, the wait time depends on local availability and how urgent the situation appears. Urgent suspected cancer referrals are typically fast-tracked, while biopsies for chronic conditions like liver disease or celiac disease may take longer to schedule. You can ask your referring doctor whether the biopsy needs to happen within days or whether a few weeks is acceptable. Knowing the urgency level helps you manage the anxiety of waiting.
Biopsies in Children
Pediatric biopsies follow the same general principles but with added considerations around sedation, size, and risk. A large review of over a thousand biopsies in children with cancer found that about 90% of biopsies provided a definitive diagnosis.22PubMed Central. Safety and Diagnostic Accuracy of Tumor Biopsies in Children with Cancer The overall adverse-event rate was under 8%, with major complications occurring in about 3% of cases. Biopsy site and pre-procedure blood counts were the strongest predictors of complications. Percutaneous core-needle biopsy in children has been shown to provide diagnostic tissue over 94% of the time, offering an alternative to open surgical biopsy that is less invasive and avoids the larger wound and longer recovery.23Techniques in Vascular and Interventional Radiology. Percutaneous Core Needle Biopsy: Considerations in the Pediatric Patient
Brainstem tumors in children present one of the more dramatic biopsy scenarios. A meta-analysis pooling results from over a thousand pediatric brainstem biopsies found that stereotactic needle biopsy yielded a diagnosis about 97% of the time, with temporary neurological complications in around 6% and permanent ones in about 1%.24World Neurosurgery. Safety and Technical Efficacy of Pediatric Brainstem Biopsies: An Updated Meta-Analysis of 1000+ Children Most of these procedures used frame-based or robotic stereotactic systems. The high diagnostic yield has shifted the conversation in pediatric neuro-oncology toward biopsying lesions that might previously have been treated empirically based on imaging alone.
Cost Differences Across Settings
Where a biopsy is performed and what imaging is used can make a major difference in cost. Prostate biopsies illustrate this vividly. MRI-guided prostate biopsies had a median cost of about $4,400, compared to lower costs for ultrasound-guided transrectal and transperineal approaches. The most expensive combination was an MRI-guided biopsy done in a hospital with anesthesia, averaging nearly $5,800 per episode. The least expensive was a transperineal biopsy performed in a physician’s office without anesthesia, with patient cost-sharing of roughly $168, compared to around $890 for an MRI-guided biopsy at an ambulatory surgical center with anesthesia.25PubMed. Payments and Patient Cost Sharing for Prostate Biopsies According to Image Guidance, Practice Site and Use of Anesthesia Imaging, especially MRI, was the biggest cost driver, accounting for the largest share of MRI-guided biopsy charges.
These numbers are specific to prostate biopsies, but the pattern generalizes: hospital settings cost more than outpatient offices, procedures with sedation or general anesthesia cost more than those with local numbing alone, and MRI or CT guidance costs more than ultrasound. If your doctor offers a choice of settings or approaches and the clinical outcomes are expected to be equivalent, it is reasonable to ask about the cost difference. Insurance coverage and deductible structures make the out-of-pocket impact unpredictable, so getting a cost estimate from the facility beforehand is worth the effort.
Liquid Biopsy and the Shift Away from Tissue
Not every diagnostic biopsy requires putting a needle into solid tissue. Liquid biopsy, which analyzes tumor DNA circulating in the blood, has emerged as a genuinely useful complement to traditional tissue sampling. The first FDA-approved liquid biopsy test was designed to detect specific mutations in non-small cell lung cancer, allowing doctors to identify patients eligible for targeted therapy through a simple blood draw rather than an invasive procedure.26PubMed Central. The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer? The appeal is obvious: a blood draw is easy to repeat, carries almost no risk, and can be used to track how a tumor’s genetic profile changes over time during treatment.
Liquid biopsy does not yet replace tissue biopsy for the initial diagnosis of most cancers. You still need a tissue sample to confirm that cancer is present, determine its type, and assess its grade under a microscope. But for patients who are too sick for an invasive biopsy, whose tumors are in hard-to-reach locations, or who need repeat testing to monitor for resistance mutations, a blood draw can provide molecular information that would otherwise require another needle or another surgery. The technology is expanding rapidly, with tests now available for multiple cancer types and at various stages of the disease.